Skip to main content
Home

Main navigation

  • Company
    • Company profile
    • Leadership team
    • Scientific Advisory Board
    • Board of Directors
  • R&D Programs
    • Pipeline overview
    • DIACC3010
    • DIACC2010/DIACC2020
  • Partnering
  • Media
    • Media hub
    • All press releases
    • All events
    • Media center
  • Careers
  • Contact
  • Search
  1. Home
  2. Media

Media center

  • BioSpace

    Diaccurate Adds Merck PAM Inhibitor to Oncology/Immunology Pipeline

    September 9, 2021
  • EndPoints

    Merck KGaA entrusts secretive startup with a mid-stage cancer drug targeting master signaling pathway

    September 8, 2021
  • BioWorld

    Could HIV be cured by tackling ‘bumpy’ CD4 cells? France’s Diaccurate wants to find out

    August 12, 2021
  • Philippe Pouletty explains the discovery of Diaccurate on the BFM Business show (in French)

    March 4, 2020
  • LesEchos

    Diaccurate opens a new therapeutic avenue for AIDS (in French)

    March 4, 2020
  • Usine Nouvelle

    Major discovery by French biotech Diaccurate in the treatment of AIDS, with the promise of remission (in French)

    March 3, 2020

Location

Headquarters: 104 Bd de Sébastopol, 75003 Paris

  33 (0)1 78 96 41 70

Stay in touch

Subscribe to our newsletter

Contact us

Follow us

   

Footer

  • Legal info
  • Privacy notice
  • Cookies notice